Cancer patients are at high risk of developing disseminated candidiasis (2, 18, 19, 28) . In many patients, the gastrointestinal tract is the source of dissemination (2, 13, 29) . Treatment with broad-spectrum antibiotics increases the risk of candidiasis in susceptible hosts by increasing the concentration of Candida organisms in the gastrointestinal tract. We recently described an adult mouse model of sustained gastrointestinal colonization by Candida albicans (27) . In the present study, we report the effects of seven commonly used antibacterial agents on the level of gastrointestinal colonization by C. albicans in this adult mouse model.
Fifty Crl:CD1 (ICR) BR mice, 3 months old and weighing approximately 30 g each (Charles River Laboratories, Wilmington, Mass.), were used in experiments with each antibiotic. The gastrointestinal tracts of 30 of these mice were colonized with C. albicans by feeding the mice for 2 weeks with chow containing the yeast by a method described previously (27) . The remaining 20 mice of each group were fed regular chow not containing C. albicans. The level of colonization was verified 1 week after the feeding period by stool cultures (27) . Subsequently, 20 mice of each group colonized with C. albicans were injected subcutaneously with the study antibiotic for 10 days. The remaining 10 colonized mice were injected (subcutaneously) with the same volume (30 ,ul) limited antibacterial activities (gentamicin, ceftazidime, aztreonam) (5, 10, 15, 21, 28, 30) . Imipenem, which has the broadest spectrum of activity but does not reach significant intestinal concentrations, did not cause a high increase in C. albicans colonization (20, 24, 25) . Findings similar to ours have been reported for both animals and humans (1, 4, 8, 9, 12, 16, 17, 23, 26, 31) . In humans, cefoperazone (8, 17) , ceftriaxone (9) , and broad-spectrum penicillins such as piperacillin (8) 
